Comparison · Updated April 2026

Compounded vs. brand-name GLP-1s: same molecule, different price.

Compounded semaglutide and tirzepatide use the same FDA-approved active ingredients as Ozempic, Wegovy, Mounjaro, and Zepbound, at roughly 1/4 the cash price. Same molecule, same mechanism, same trial-validated weight-loss outcomes. What differs is delivery format, dose flexibility, and how fast you can actually get a prescription.

Start consultation, $0
LegitScript CertifiedLegitScript CertifiedHealthcare Merchant

Head-to-head comparison

AspectCompounded (OPTML)Brand-Name (Ozempic, Wegovy, Mounjaro, Zepbound)
Active ingredient✓ Same FDA-approved molecule✓ Same FDA-approved molecule
Clinical effectiveness✓ Identical mechanism of action✓ Identical mechanism of action
Typical monthly cost✓ $199 - $299 cash pay✗ $1,000 - $1,349 cash pay (when not covered)
Availability✓ Widely available through telehealth✗ Often insurance-gated or back-ordered
Dose flexibility✓ Custom micro-doses to match your tolerance✗ Fixed-dose pens only
Time-to-prescription✓ 24-hour provider review, 2-3 day shipping✗ Often weeks of insurance back-and-forth
Provider oversight✓ U.S.-licensed physician + ongoing messagingDepends on prescribing path
Pharmacy regulation✓ State-licensed, FDA-registered 503A pharmacies under USP <797>✓ FDA-approved finished drug product
AdministrationVial + syringe (subcutaneous), same injection site, same volumePre-filled pen (subcutaneous)
Optional B12 / glycine carriers✓ Available on request, supports tolerance for some patients✗ Not offered
Insurance coverageCash-pay, HSA/FSA eligible (most patients pay less than copay)Sometimes covered for diagnosed conditions; copay varies
HSA / FSA eligible✓ Yes✓ Yes

Beyond GLP-1: where compounding really shines

Compounding isn't just about price on the same molecule, it's about access to formulations brand-name pharma doesn't offer at all.

ProtocolCompounded (OPTML)Brand-Name equivalent
Bioidentical HRT (estradiol + progesterone)✓ Bioidentical molecules calibrated to your numbers, $199/mo starting (HRT for women)✗ Synthetic Premarin / Provera with WHI safety concerns; one-size-fits-all dosing
Microdose GLP-1 (sub-clinical optimization)✓ $199-$299/mo with custom titration for metabolic optimization without weight loss being the goal (Microdose GLP-1)✗ Not available, fixed-dose pens start at full clinical dose
Sermorelin (GHRH peptide)✓ Compounded peptide for sleep, recovery, and GH optimization, $189/mo (Sermorelin)✗ No brand-name equivalent offered in the U.S.
TRT (testosterone cypionate)✓ Calibrated dose + cadence to your labs, $199/mo (TRT)Available as brand injectable, but typically higher cost and rigid dosing
NAD+ injection therapy✓ $179/mo, dose flexibility for tolerance (NAD+)✗ Not available as a brand-name injectable

Why compounding exists in the first place

Compounding pharmacies have operated in the U.S. for over a century, long before modern pharma manufacturing. Here's what they actually do.

503A pharmacies

Traditional compounding pharmacies, licensed by state boards and regulated under section 503A of the Federal Food, Drug, and Cosmetic Act. They prepare patient-specific medications from bulk active ingredients.

503B outsourcing facilities

A subset of larger compounding operations that must register with the FDA and meet stricter cGMP standards, essentially operating like smaller pharmaceutical manufacturers.

Why GLP-1s are compounded

GLP-1 drugs appeared on the FDA shortage list during the Ozempic/Wegovy access crisis, which created a legal pathway for 503A pharmacies to compound them. Regulation continues to evolve.

Frequently asked questions

When prepared by a licensed 503A compounding pharmacy using a pharmaceutical-grade active ingredient from an FDA-registered API supplier, compounded semaglutide and tirzepatide are generally considered to carry a similar safety profile as brand-name versions. The main risks are (1) using a non-licensed source, and (2) incorrect dosing without clinician oversight, both things OPTML controls.
Brand-name prices reflect R&D recovery, marketing, insurance negotiation, and global distribution. Compounded versions only reflect the cost of the active ingredient, pharmacy labor, and shipping, no billions-dollar-a-year marketing machine behind them.
FDA status for compounded GLP-1s is fluid and depends on whether the brand-name drugs are classified as being in shortage. Regulations may change. We monitor FDA guidance closely and will communicate directly with patients if anything affects access.
The semaglutide or tirzepatide active ingredient in a compounded formulation is the same molecule as in the brand-name drug. What may differ: excipients (carriers), concentration, added ingredients like B12, and storage requirements.
Run the math, then decide. Most patients who think their insurance "covers" a brand-name GLP-1 actually face a copay of $200-$500/mo, prior authorization delays of 2-6 weeks, denials that can resume at any renewal, and a fixed-dose pen with no titration flexibility. OPTML's compounded path is cash-pay $229-$449/mo, prescribed, ships in 2-3 days, and your dose is calibrated to your tolerance, not whatever the pen happens to be. For most cash-conscious or time-sensitive patients, compounded is the better path.

Get prescribed by a real clinician

We only compound with licensed U.S. 503A pharmacies and pair every prescription with physician oversight and optional lab work.

Start your consultation